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ORIGINAL ARTICLE VIROLOGYChikungunya infection: self-reported rheumatic morbidity and impaired
quality of life persist 6 years laterC. Marimoutou1, J. Ferraro2, E. Javelle2, X. Deparis1 and F. Simon2
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et Tropicale, Hôpital d’Instruction des Armées Laveran, Marseille, FranceAbstractThis study presents the 6-year follow-up of French gendarmes exposed to the chikungunya (CHIK) infection in 2006 on Reunion Island. The
aim was to see to what extent the subjective health differences observed in 2008 (30 months after infection) between CHIK infected (CHIK+)
and noninfected (CHIK-) gendarmes still persisted in 2012, and to investigate a possible return to a pre-CHIK health status for CHIK+
subjects. Gendarmes were contacted by mail in 2012 and asked to complete a self-questionnaire asking for morbidity, health care and
medicines consumption since the last follow-up in 2008. Quality of life (QoL) after 6 years was evaluated using the SF-36 scale. In
comparison with CHIK- subjects (n = 171), CHIK+ (n = 81) presented with higher rheumatic but also nonspeciﬁc morbidity such as
headaches and fatigue associated with a large psychological impact, frequent depressive moods and social disabilities, leading to a
signiﬁcant impairment of the QoL and higher health care consumption. When restricted to CHIK+ subjects, comparing the data with
that of 2008 showed persistent but decreasing self-reported rheumatic morbidity, and an increase over time of chronic discomfort
(headache, fatigue) and depressive moods, resulting in no overall improvement in QoL. Despite possible cohort attrition bias, the
comparability of CHIK+/CHIK- subjects allows the assumption of a long-term impact of CHIK infection with less chance of returning to
a previous health status. Although these results may be speciﬁc to the 2006 virus strain, we recommend that public health strategies in
the epidemic-prone countries include a response to the consequences of chronic post-CHIK disorders.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
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E-mail: marimoutouc@aol.comIntroductionIn 2005-2006, a large chikungunya (CHIK) outbreak reached
Reunion Island, a French overseas department in the South-
western Indian Ocean. To evaluate this phenomenon and the
risks to French military forces, all military policemen deployed
on Reunion Island in June 2006 were invited to be tested and to
answer a self-questionnaire [1]. Among the 757 gendarmesMicrobiol Infect 2015; 21: 688–693
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.02.024(members of the French military force responsible for carrying
out police duties among civilian populations) deployed, 662
(87.5%) agreed both to ﬁlling in the questionnaire and serology.
Although 23% of them self-declared to have had a CHIK
infection, only 19% had positive serology. The inquiry was
carried out 6 months on average after the acute infection. At
this time, 93.7% of the most symptomatic patients complained
of chronic rheumatic symptoms [1]. In 2008, about 30 months
after infection, the same gendarmes were contacted by mail to
report on the long-term impact of CHIK infection. Only 2/3
(N = 403) of the cohort sent back the self-questionnaire,
regardless of their self-declared CHIK status (101 self-
declared CHIK-infected [CHIK+] and 302 self-declared nonin-
fected [CHIK-]). The results showed a decreasing gradient forious Diseases. Published by Elsevier Ltd. All rights reserved
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quality of life (QoL) of life from self-declared not yet healed
CHIK+ subjects to self-declared healed CHIK+ subjects
compared to CHIK noninfected subjects [2]. Since the long-
running 2006 epidemic, numerous data have been published
on long-term post-CHIK rheumatic disorders [3–7]. Some
have studied the QoL impairment [8,9], but few have compared
them with uninfected subjects and none with a follow-up of
more than 2 years. Pooling the results of 8 different studies on
post-CHIK infection chronic symptoms in a simulation model-
ling evolution over time, the proportion of patients with post-
CHIK symptoms was estimated to approach zero after 5 years
[10]. In 2012, 6 years after the epidemic, we contacted the
gendarmes of the initial cohort. The aim was to see to what
extent the CHIK+/CHIK- subjective health differences per-
sisted at this time, and to investigate a possible return to pre-
CHIK health status for CHIK+ subjects.MethodsUsing data from the Gendarmerie headquarters, 646 partici-
pants in the 2006 enquiry were identiﬁed and sent letters
containing information on the previous follow-up results, a
description of the current study’s purpose, an informed con-
sent form to participate, a separate proposal for new biological
tests (data not presented due to low acceptance rate) and a
self-questionnaire.
The questions concerned CHIK infection (yes/no), healing
(yes/no), rheumatic and nonrheumatic symptoms (frequency:
never/monthly/weekly/daily/permanent and intensity: none/low
intense/quite intense/very intense), health care consumption
(number of medical and paramedical consultations since 2008),
how often medicines are taken (pain killers and anti-
inﬂammatory drugs): never/once per month; once per
week; 3 days/week, daily, ability to work (two questions:TABLE 1. Rheumatic symptoms according to chikungunya infection
cohort, n [ 252
Pain Stiffne
CHIK+
n [ 81 (%)
CHIK–
n [ 171 (%)
CHIK
n [ 8
Frequency*
Never 24 (30) 113 (66) 38 (47
Once/month 26 (32) 29 (17) 16 (20
Once/week 13 (16) 14 (8) 8 (10)
Daily 18 (22) 15 (9) 19 (23
Intensity*
No or low pain 42 (52) 143 (84)
Moderate to intense 39 (48) 28 (16)
*p < 0.0001.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyability with or without restriction/modiﬁcation of employment,
and change in perceived ability to perform current job), sick
leave since the last follow-up and current QoL estimated using
the MOS-SF-36 scale.
In this study, patients were classiﬁed as CHIK+ or CHIK- ac-
cording to their self-declaration. CHIK+ were those who
answered “yes” to the question “Do you think you have been
infected by chikungunya?” regardless of their 2006 serology test
results, and CHIK- those who answered “no”. This choice was
made in order to be consistent with the previous publications on
the 2008 enquiry that used the same deﬁnition. On both occa-
sions, there was a great concordance between self-declaration
and the serological results (especially for CHIK-seronegative
gendarmes) and a great consistency between CHIK status and
reported symptoms. On the other hand, some questions per-
sisted on the serological results as interaction with cry-
oglobulinemia led to some misclassiﬁcations in 2006 (25% of
positive serology were identiﬁed only after warming plasma), and
we could not have new testing for the 2012 responders.
Only 609 gendarmes were reached, and 252 completed the
questionnaire: 81 CHIK+ and 171 CHIK-. As 49% of CHIK+
subjects answered “I do not know” to the question “do you
consider that you are healed of CHIK-infection?” (29%
answered “no” and 22% “yes”), all analyses compared only two
groups, the CHIK+ (regardless of healing) vs. the CHIK- sub-
jects, using χ2 or Fisher exact test for qualitative variables and
the Wilcoxon rank sum test for quantitative ones.ResultsPatients were 95% male and had a median age of 44 years.
CHIK+ patients complained of more frequent and intense
joint pain than CHIK - (38% vs. 17% declared suffering at least
once a week; 48% vs. 16% declared moderate to intense pain,
p 0.0001, Table 1). The difference increased with thestatus 6 years after chikungunya epidemic, French gendarmes
ss Swelling
+
1 (%)
CHIK–
n [ 171 (%)
CHIK+
n [ 81 (%)
CHIK–
n [ 171 (%)
) 140 (82) 65 (80) 168 (98)
) 15 (9) 10 (12) 2 (1)
5 (3) 2 (3) —
) 11 (6) 4 (5) 1 (1)
and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 688–693
TABLE 2. Nonrheumatic symptoms according to chikungunya infection status 6 years after chikungunya epidemic, French
gendarmes cohort, n [ 252
Fatigue* Headache† Depressive mood*‡
CHIK+
n [ 81 (%)
CHIK–
n [ 171 (%)
CHIK+
n [ 81 (%)
CHIK–
n [ 171 (%)
CHIK+
n [ 81 (%)
CHIK–
n [ 171 (%)
Frequency
Never 32 (40) 116 (68) 47 (58) 122 (71) 64 (79) 160 (93)
Monthly 21 (26) 29 (17) 18 (22) 33 (19) 12 (15) 9 (5)
Weekly 18 (22) 16 (9) 15 (19) 16 (10) 3 (4) 1 (1)
Daily 10 (12) 10 (6) 1 (1) — 2 (3) 1 (1)
*p < 0.001.
†p 0.04 (three classes: never, monthly, weekly or daily).
‡Two classes: never vs. at least monthly.
690 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIspeciﬁcity and disabling character of rheumatic symptoms
rarer than pain, such as stiffness and swelling. Stiffness once
per month was declared at least 3 times more frequently by
CHIK+ than by CHIK- subjects, and swelling 10 times more
frequently (Table 1). The frequency of nonrheumatic
symptoms was markedly higher among CHIK+ subjects. Fa-
tigue, headache and depressive moods were declared at least
once a week by 34%, 20% and 7% of CHIK+ patients,
respectively, compared with 15%, 10% and 2% of CHIK-
subjects (Table 2).
In addition, CHIK+ patients declared higher health care
consumption needs between 2008 and 2012. Signiﬁcant differ-
ences concerned a greater likelihood of consultations with
general practitioners (93% of CHIK+ consulted vs. 82% of
CHIK-, p 0.03) and frequency (6.5 consultations per subject
among CHIK+ vs. 4.5 among CHIK-), but also with physio-
therapists (4 consultations vs. 3) and osteopathy (1.5 vs. 0.5,
Fig. 1). The most frequent medication taken was paracetamol
(taken at least once during the period by 77% of CHIK+ sub-
jects vs. 45% of CHIK-, p < 0.001), followed by nonsteroidalClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectanti-inﬂammatory drugs (taken by 46% of CHIK+ vs. 26% of
CHIK-, p 0.002) and aspirin (taken by 29% of CHIK+ and 11%
CHIK-, p < 0.001). The frequency of use differed signiﬁcantly
only for paracetamol taken at least once a week by 40% of
CHIK+ users vs. 10% of CHIK- users, p < 0.001 (Fig. 2).
There was no difference between CHIK+ and CHIK- sub-
jects concerning professional incapacity (about 16% retired or
with partial incapacity), but CHIK+ tended to take more sick
leave during this period (median: 1 [interquartile: 0-2] vs. me-
dian: 0 [interquartile: 0-1] declared by CHIK-, p 0.05]. CHIK+
subjects declared more frequently the perception of having
difﬁculties in performing their work (47% CHIK+ vs. 24%
CHIK-, p 0.0002). They also were more likely to declare social
disability (46% CHIK+ vs. 16% CHIK- declared permanent or
intermittent social disability, p < 0.0001).
Finally, all aspects of SF36 QoL were signiﬁcantly impaired in
CHIK+ patients compared to CHIK-, reﬂecting the social,
physical and mental impact of this disease. Moreover, the 2012
QoL was exactly stackable to the 2008 QoL, regardless of the
CHIK status (Fig. 3).FIG. 1. Mean consultations per
subject between 30 months and 6-
year follow-up, according to CHIK
status, cohort of French gendarmes.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 688–693
FIG. 2. Frequency of paracetamol of consumption according to CHIK
status between 30 months and 6-year follow-up according to CHIK
status, cohort of French gendarmes.
CMI Marimoutou et al. Six-year post-CHIK overmorbidity and impaired QoL 691DiscussionThis is the ﬁrst study providing observational data such a long
time after a CHIK infection. It showed signiﬁcant self-reported
overmorbidity and impaired QoL persisting in CHIK+ patients
compared to CHIK- subjects 6 years after the CHIK infection.
The cohort attrition was high, but it was much higher among
CHIK- than among the CHIK+, authorizing valuable compari-
sons in a homogenous population regardless of the CHIK
infection. This comparability between CHIK+ and CHIK- sub-
jects served to remove the aging effect on rheumatic disorders.FIG. 3. Quality of life aspects (SF-36
QoL scale) according to chikungunya
status and year of follow-up, cohort
of French gendarmes.
Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyAnother potential bias was that CHIK+ responders could be
the most symptomatic, leading to an overestimation of the
differences observed. However, the gap between CHIK+ and
CHIK- was large enough not to be closed by the addition of
20% CHIK+ patients (proportion of nonresponders) less
affected by the infection (i.e. not signiﬁcantly different to CHIK-
subjects). The self-reported classiﬁcation of CHIK+ subjects
may have led us either to underestimate differences, if the
misclassiﬁed CHIK+ were those who reported less frequent
symptoms, or to overestimate it, if they self-classiﬁed CHIK+
because they had frequent symptoms but also they were
actually CHIK-. Both occurrences probably balanced out in the
sample. Thus, the post-CHIK long-term impact on self-
perceived health conditions cannot be ignored, and persists
longer than the 5 years calculated by modelling the early
chronic data [10]. In addition, this was observed in young
healthy workers, mainly men, who are not the most at risk for
chronic post-CHIK musculoskeletal or rheumatic disorders
(rather reported in women over 45 years old) [11].
In this study, although self-reported musculoskeletal disor-
ders, including swelling and stiffness, were more prevalent
among CHIK+ compared to CHIK- subjects, no severe in-
ﬂammatory rheumatism was reported among CHIK+ gen-
darmes (i.e. no chronic polyarthritis). As severe inﬂammatory
rheumatism was reported in about 5% of patients after the
CHIK infection [11], it can be suggested that the functional
overmorbidity observed in our cohort represents the main
thrust of the post-CHIK musculoskeletal consequences, with aand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 688–693
692 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIfavourable but very extended outcome. Among CHIK+, self-
reported musculoskeletal disorders were less frequent and
intense than those reported during the 2008 follow-up [2]. The
20% CHIK+ still reporting recurrent joint swelling suggests the
presence of neurovascular disorders such as postinfectious
complex regional pain syndrome [12] or undiagnosed under-
lying inﬂammatory rheumatism.
Importantly, contrary to the decreasing self-reported rheu-
matic morbidity, reports of chronic discomfort (headache, fa-
tigue) had increased with time. In 2008, only 17% and 14% of
CHIK+ subjects reported fatigue and headache, respectively, at
least once a month compared to 60% and 42% after 6 years [2].
In addition, 22% CHIK+ patients reported depressive moods at
least once a month at this follow-up compared to 4% in 2008
[2]. Some of the difference may be explained by the different
way of recording the information (a monthly divided table with
a list of symptom to quote each month they were present in the
2008 questionnaire and questions on the rhythm of each
speciﬁed symptom in 2012). Once again the large difference
between 2008 and 2012 suggests at least no decrease in this
chronic post-CHIK unspeciﬁc morbidity that may increase
(particularly the depression) due to the perception of having no
end in sight. The large psychological impact of the disease
associating frequent depressive moods and social disabilities
ruined patients’ QoL, but may also explain why half the patients
could not decide whether to self-classify as healed or not, as
reported in other studies [8].
The study also observed a higher health care and drug
consumption in CHIK+ patients compared to CHIK- subjects.
The overconsumption of drugs mainly concerned paracetamol,
which corresponded with the common morbidity reported by
CHIK+, such as headache and common musculoskeletal dis-
orders. Health care consumption by subject seemed lower in
the current study than in 2008: 6.5 general practitioner con-
sultations by CHIK+ patients over the 4 years of follow-up
compared to 5.5 for 2 years in 2008 [2], which is consistent
with the decline in reported rheumatic symptoms.
The global overmorbidity of CHIK+ patients did not have
insurmountable professional consequences, in particular
regarding the ability to work. However, CHIK+ patients were
more likely to report having difﬁculty carrying out their work
and tended to report more sick leave. The subjective post-
CHIK physical, mental and social health perceptions got
worse, although the rheumatic disorders had favourable out-
comes. Globally, the impairment of QoL has remained stable
since the 2008 follow-up in CHIK+ patients, over all aspects.
This self-perceived impaired QoL is more likely to be related to
nonspeciﬁc morbidity. In response to our objective, this long-
lasting impaired QoL suggests no return to the previous
health status after a CHIK infection.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectThe QoL results concerned the 2006 CHIK virus strain from
Reunion Island and a cohort of young healthy active men who
may have a lower tolerance for disability, so extrapolation is
limited. New observations from the current epidemic in the
Americas are keenly awaited to determine if the chronic
outcome is as long with another viral strain (Asian) and genetic
terrain. Meanwhile, based on our data at 6 years, we recom-
mend that public health strategies in epidemic-prone countries
include a response to chronic post-CHIK disorders, including
the education of health care workers, information for infected
people and social measures for patients with severe and pro-
longed consequences of the disease.Transparency declarationThis work was supported by a grant from the Central Direc-
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